Aspire Biopharma Holdings, Inc. (ASBP) Earnings History
Annual and quarterly earnings data from 2022 to 2024
Loading earnings history...
ASBP EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
ASBP Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
Download Data
Export ASBP earnings history in CSV or JSON format
Free sign-in required to download data
Aspire Biopharma Holdings, Inc. (ASBP) Earnings Overview
As of May 8, 2026, Aspire Biopharma Holdings, Inc. (ASBP) reported trailing twelve-month net income of -$32M. The company earned $-0.64 per diluted share over the past four quarters.
Looking at the long-term picture, ASBP's historical earnings data spans multiple years. The company achieved its highest annual net income of -$359,071 in fiscal 2023.
Aspire Biopharma Holdings, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including CRBP (-$79M net income), YCBD (-$328M net income, -10.6% margin), XXII (-$4M net income, -28.7% margin), ASBP has comparable earnings metrics. Compare ASBP vs CRBP →
ASBP Earnings vs Peers
Earnings metrics vs comparable public companies
ASBP Historical Earnings Data (2022–2024)
3 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$13M | -3391.6% | -$3M | $-0.26 | - | - |
| 2023 | $-359,071 | +39.9% | $-358,590 | $-0.01 | - | - |
| 2022 | $-597,117 | - | $-596,491 | $-0.01 | - | - |
See ASBP's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ASBP Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ASBP vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonASBP — Frequently Asked Questions
Quick answers to the most common questions about buying ASBP stock.
Is ASBP growing earnings?
ASBP TTM EPS: $-0.64. Net income: $-32M. Earnings growth: N/A.
What are ASBP's profit margins?
Aspire Biopharma Holdings, Inc. net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are ASBP's earnings?
ASBP earnings data spans 2022-2024. The current earnings trend is N/A YoY. Historical data enables comparison across business cycles.